A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Wasserman, MD
Inspirna, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Oncology
Tucson, Arizona, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- University of Colorado
Aurora, Colorado, United States
- Rocky Mountain Cancer Centers
Denver, Colorado, United States
- Sarah Cannon Research Institute
Denver, Colorado, United States
- Florida Cancer Specialist
Lake Mary, Florida, United States
- Comprehensive Hematology Oncology
St. Petersburg, Florida, United States
- James Graham Brown Cancer Center
Louisville, Kentucky, United States
- Ochsner Clinic Foundation
New Orleans, Louisiana, United States
- Maryland Oncology
Columbia, Maryland, United States
- Regions Hospital
Saint Paul, Minnesota, United States
- Dartmouth Hitchcock Medical
Lebanon, New Hampshire, United States
- Cinj
New Brunswick, New Jersey, United States
- Quantum Santa Fe
Santa Fe, New Mexico, United States
- Columbia University Medical Center
New York, New York, United States
- Ou Health Stephenson Cancer Center
Oklahoma City, Oklahoma, United States
- Oregon Health Sciences University
Portland, Oregon, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
- the Sarah Cannon Research Institute
Nashville, Tennessee, United States
- Virginia Cancer Specialists, Pc
Fairfax, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Nov 2016
- Primary completion
- 22 Jan 2025
- Completion
- 22 Jan 2025
- Last update posted
- 26 Mar 2025
- Registered enrollment
- 146
- Registry id
- NCT02922764
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.